Cargando…

Expression of L-Type Amino Acid Transporter 1 is a Predictive Biomarker of Intravesical Recurrence in Patients with Non-Muscle Invasive Bladder Cancer

PURPOSE: L-type amino acid transporter 1 (LAT1), a Na(+)-independent amino acid transporter, is highly expressed in various cancer types. We evaluated the prognostic value of LAT1 expression in non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS: We retrospectively reviewed 119 consecut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawazaki, Harutake, Arai, Yuichi, Ito, Yuji, Sato, Kimiya, Tsuda, Hitoshi, Yamaga, Takashi, Sakurai, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387640/ https://www.ncbi.nlm.nih.gov/pubmed/34458203 http://dx.doi.org/10.2147/RRU.S326249

Ejemplares similares

Expressions of P-Glycoprotein, Multidrug Resistance Protein 1 and Annexin A2 as Predictive Factors for Intravesical Recurrence of Bladder Cancer after the Initial Transurethral Resection and Immediate Single Intravesical Instillation of Adriamycin
por: Sawazaki, Harutake, et al.
Publicado: (2021)

A case of squamous cell carcinoma arising from a suprapubic cystostomy tract in a patient with spinal bifida: Immunohistochemical analysis and literature review
por: Sawazaki, Harutake, et al.
Publicado: (2022)

Combined antegrade and retrograde endoscopic treatment of complete ureteroenteric obstruction following cystectomy with ileal conduit: A case report
por: Sawazaki, Harutake, et al.
Publicado: (2020)

Malignant fibrous histiocytoma arising from the renal capsule and gene mutation screening: A case report
por: Sawazaki, Harutake, et al.
Publicado: (2019)

Androgen receptor‐neuroendocrine double‐negative tumor with squamous differentiation arising from treatment‐refractory metastatic castration‐resistant prostate cancer
por: Sawazaki, Harutake, et al.
Publicado: (2021)

Massive Renal Replacement Lipomatosis With Foci of Xanthogranulomatous Pyelonephritis in a Horseshoe Kidney
por: Sawazaki, Harutake, et al.
Publicado: (2017)

Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer
por: Kuroda, Kenji, et al.
Publicado: (2020)

Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report
por: ITO, KEIICHI, et al.
Publicado: (2014)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Induction of CTH expression in response to amino acid starvation confers resistance to anti-LAT1 therapy in MDA-MB-231 cells
por: Yamaga, Takashi, et al.
Publicado: (2022)

Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
por: Ord, J J, et al.
Publicado: (2005)

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
por: Woodcock, Victoria K., et al.
Publicado: (2023)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Intravesical Agents in the Treatment of Bladder Clots in Children
por: Della Corte, Marcello, et al.
Publicado: (2023)

Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy?
por: Dray, Elizabeth V., et al.
Publicado: (2017)

Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data
por: Tsukamoto, Ryo, et al.
Publicado: (2023)

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
por: Douglass, Laura, et al.
Publicado: (2016)

Device-assisted intravesical therapy for non-muscle invasive bladder cancer
por: Hendricksen, Kees
Publicado: (2019)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
por: Liu, Kang, et al.
Publicado: (2020)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017)

Chronic lymphocytic leukemia and concurrent seminoma in the same testis
por: Miyai, Kosuke, et al.
Publicado: (2022)

Factors effecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG
por: Kashif Khan, Muhammad, et al.
Publicado: (2014)

Correlation of Male Overactive Bladder with Intravesical Prostatic Protrusion
por: Kim, Ki Hong, et al.
Publicado: (2010)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Intravesical therapy for bladder cancer in the pandemic of Covid-19
por: Teoh, Jeremy Y. C., et al.
Publicado: (2020)

Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3(+) T cells in the primary transurethral resection of bladder tumor specimens
por: Murai, Ryosuke, et al.
Publicado: (2018)

Modulation of Bladder Wall Micromotions Alters Intravesical Pressure Activity in the Isolated Bladder
por: Chakrabarty, Basu, et al.
Publicado: (2019)

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
por: Serretta, Vincenzo, et al.
Publicado: (2015)

Intravesical recurrence of chromophobe renal cell carcinoma
por: Kelly, Niall P., et al.
Publicado: (2023)

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy
por: Moustakas, Georgios, et al.
Publicado: (2020)

Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma
por: Kawamura, Kazuki, et al.
Publicado: (2023)

The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia
por: Wang, Chengbo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7sob8507o8bsvrl445kl4qkj9n